Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: Delali Attipoe
Legal name: Drugs for Neglected Diseasesinitiative NORTH America Inc
Other name: Drugs for Neglected Diseases Initiative
EIN 20-8774179 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The drugs for neglected diseases initiative (dndi), North America supports dndi's global vision and mission to develop new drugs, or new formulations of existing drugs for patients suffering from the most neglected diseases. Acting in the public interest, dndi bridges existing r&d gaps in essential drugs for these diseases by initiating and coordinating drug r&d projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other partners.
Principal Officer
Darin Portnoy
Total Revenue
$6.2M
FY2024
Total Expenses
$6.3M
FY2024
Net Assets
$977K
Program Ratio
80.6%
expenses on programs
Employees
12
Volunteers
12
Board Members
8
Voting
8
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.